To hear about similar clinical trials, please enter your email below
Trial Title:
Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment
NCT ID:
NCT06630442
Condition:
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Conditions: Official terms:
Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Active, not recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Educational Intervention
Description:
Attend a food safety educational training program
Arm group label:
Supportive care (food safety educational training)
Other name:
Education for Intervention
Other name:
Intervention by Education
Other name:
Intervention through Education
Other name:
Intervention, Educational
Intervention type:
Other
Intervention name:
Questionnaire Administration
Description:
Ancillary studies
Arm group label:
Supportive care (food safety educational training)
Summary:
This clinical trial evaluates the impact of a food safety educational training program on
food safety knowledge and behaviors in cancer patients receiving treatment. Cancer
treatments, such as chemotherapy, can put patients at risk for foodborne infections and
despite this risk, it has been reported that patients do not receive any food safety
counseling until they are already experiencing low white blood cell counts. A food safety
educational training program may help cancer patients make better choices of low-risk
foods and prepare foods safely.
Detailed description:
PRIMARY OBJECTIVE:
I. Evaluate the efficacy of a food safety education intervention for cancer patients.
OUTLINE:
Patients attend a food safety educational training program over 50 minutes on study.
After completion of study intervention, patients are followed up at 5 weeks.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Participants must be at least 18 years of age
- Able to fluently read and converse in English (though it does not have to be their
first language)
- All participants must be diagnosed with cancer, any stage, and be receiving some
form of treatment at the aforementioned facilities
- Informed consent must be obtained from each patient prior to participation in any
aspect of the study
Exclusion Criteria:
- Patients who do not meet these criteria or are not willing or are unable to give
informed consent, will be excluded from this study
- Patients with prescribed dietary limitations or currently on neutropenic diet
unrelated to this study will not be included
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Ohio State University Comprehensive Cancer Center
Address:
City:
Columbus
Zip:
43210
Country:
United States
Start date:
February 21, 2022
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Ohio State University Comprehensive Cancer Center
Agency class:
Other
Source:
Ohio State University Comprehensive Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06630442
http://cancer.osu.edu
